123 related articles for article (PubMed ID: 14653893)
1. Administration of recombinant human FSH (solution in cartridge) with a pen device in women undergoing ovarian stimulation.
Pang S; Kaplan B; Karande V; Westphal LM; Scott R; Givens C; Sacks P;
Reprod Biomed Online; 2003 Oct; 7(3):319-26. PubMed ID: 14653893
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a pen device for self-administration of recombinant human FSH in clomiphene citrate-resistant anovulatory women undergoing ovulation induction.
Kettel LM; Scholl G; Bonaventura L; Pang S; Sacks P; Chantilis S; Mahony M;
Reprod Biomed Online; 2004 Oct; 9(4):373-80. PubMed ID: 15511333
[TBL] [Abstract][Full Text] [Related]
3. An open, randomized single-centre study to compare the efficacy and convenience of follitropin beta administered by a pen device with follitropin alpha administered by a conventional syringe in women undergoing ovarian stimulation for IVF/ICSI.
Platteau P; Laurent E; Albano C; Osmanagaoglu K; Vernaeve V; Tournaye H; Camus M; Van Steirteghem A; Devroey P
Hum Reprod; 2003 Jun; 18(6):1200-4. PubMed ID: 12773446
[TBL] [Abstract][Full Text] [Related]
4. Comparison of follitropin-beta administered by a pen device with conventional syringe in an ART programme - a retrospective study.
Rama Raju GA; Suryanarayana K; Jaya Prakash G; Murali Krishna K
J Clin Pharm Ther; 2008 Aug; 33(4):401-7. PubMed ID: 18613858
[TBL] [Abstract][Full Text] [Related]
5. Patient and nurse evaluation of recombinant human follicle-stimulating hormone administration methods: comparison of two follitropin injection pens.
Porter R; Kissel C; Saunders H; Keck C
Curr Med Res Opin; 2008 Mar; 24(3):727-35. PubMed ID: 18230195
[TBL] [Abstract][Full Text] [Related]
6. Patient evaluation of the use of follitropin alfa in a prefilled ready-to-use injection pen in assisted reproductive technology: an observational study.
Welcker JT; Nawroth F; Bilger W
Reprod Biol Endocrinol; 2010 Sep; 8():111. PubMed ID: 20843323
[TBL] [Abstract][Full Text] [Related]
7. Economic evaluation of the administration of follitropin-beta with a pen device.
Bruynesteyn K; Bonsel GJ; Braat DD; Fauser BC; Devroey P; van Genugten ML
Reprod Biomed Online; 2005 Jul; 11(1):26-35. PubMed ID: 16102283
[TBL] [Abstract][Full Text] [Related]
8. Concurrent ganirelix and follitropin beta therapy is an effective and safe regimen for ovulation induction in women with polycystic ovary syndrome.
Elkind-Hirsch KE; Webster BW; Brown CP; Vernon MW
Fertil Steril; 2003 Mar; 79(3):603-7. PubMed ID: 12620447
[TBL] [Abstract][Full Text] [Related]
9. Clinical efficacy of the gonadotropin-releasing hormone antagonist, ganirelix, in Korean women undergoing controlled ovarian hyperstimulation for in vitro fertilization and embryo transfer with recombinant follicle-stimulating hormone.
Moon SY; Ku SY; Kim SM; Jee BC; Suh CS; Choi YM; Kim JG; Kim SH
J Obstet Gynaecol Res; 2005 Jun; 31(3):227-35. PubMed ID: 15916659
[TBL] [Abstract][Full Text] [Related]
10. A pen injection device for self-administration of recombinant follicle-stimulating hormone for fertility treatments.
Pang SC
Expert Rev Med Devices; 2005 Jan; 2(1):27-32. PubMed ID: 16293025
[TBL] [Abstract][Full Text] [Related]
11. A double-blind, randomized, dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle stimulating hormone (Puregon). The ganirelix dose-finding study group.
Hum Reprod; 1998 Nov; 13(11):3023-31. PubMed ID: 9853849
[TBL] [Abstract][Full Text] [Related]
12. Large, comparative, randomized double-blind trial confirming noninferiority of pregnancy rates for corifollitropin alfa compared with recombinant follicle-stimulating hormone in a gonadotropin-releasing hormone antagonist controlled ovarian stimulation protocol in older patients undergoing in vitro fertilization.
Boostanfar R; Shapiro B; Levy M; Rosenwaks Z; Witjes H; Stegmann BJ; Elbers J; Gordon K; Mannaerts B;
Fertil Steril; 2015 Jul; 104(1):94-103.e1. PubMed ID: 26003273
[TBL] [Abstract][Full Text] [Related]
13. Ovarian stimulation in women undergoing in-vitro fertilization and embryo transfer using recombinant human follicle stimulating hormone (Gonal-F) in non-down-regulated cycles.
Strowitzki T; Kentenich H; Kiesel L; Neulen J; Bilger W
Hum Reprod; 1995 Dec; 10(12):3097-101. PubMed ID: 8822421
[TBL] [Abstract][Full Text] [Related]
14. High doses of gonadotrophin-releasing hormone antagonist in in-vitro fertilization cycles do not adversely affect the outcome of subsequent freeze-thaw cycles.
Kol S; Lightman A; Hillensjo T; Devroey P; Fauser B; Tarlatzis B; Mannaerts B; Itskovitz-Eldor J
Hum Reprod; 1999 Sep; 14(9):2242-4. PubMed ID: 10469687
[TBL] [Abstract][Full Text] [Related]
15. A randomized prospective trial comparing gonadotropin-releasing hormone (GnRH) antagonist/recombinant follicle-stimulating hormone (rFSH) versus GnRH-agonist/rFSH in women pretreated with oral contraceptives before in vitro fertilization.
Barmat LI; Chantilis SJ; Hurst BS; Dickey RP
Fertil Steril; 2005 Feb; 83(2):321-30. PubMed ID: 15705369
[TBL] [Abstract][Full Text] [Related]
16. Low-dose GnRH antagonist protocol is as effective as the long GnRH agonist protocol in unselected patients undergoing in vitro fertilization and embryo transfer.
Huang SY; Huang HY; Yu HT; Wang HS; Chen CK; Lee CL; Soong YK
Taiwan J Obstet Gynecol; 2011 Dec; 50(4):432-5. PubMed ID: 22212313
[TBL] [Abstract][Full Text] [Related]
17. A retrospective comparison of clinical outcomes and satisfaction using reconstituted recombinant gonadotropins (rFSH) or cartridge rFSH with a pen device in donor oocyte cycles.
Christianson MS; Barker MA; Schouweiler C; Lindheim SR
Curr Med Res Opin; 2007 Apr; 23(4):865-70. PubMed ID: 17407643
[TBL] [Abstract][Full Text] [Related]
18. A randomized assessor-blind trial comparing highly purified hMG and recombinant FSH in a GnRH antagonist cycle with compulsory single-blastocyst transfer.
Devroey P; Pellicer A; Nyboe Andersen A; Arce JC;
Fertil Steril; 2012 Mar; 97(3):561-71. PubMed ID: 22244781
[TBL] [Abstract][Full Text] [Related]
19. First live birth after ovarian stimulation using a chimeric long-acting human recombinant follicle-stimulating hormone (FSH) agonist (recFSH-CTP) for in vitro fertilization.
Beckers NG; Macklon NS; Devroey P; Platteau P; Boerrigter PJ; Fauser BC
Fertil Steril; 2003 Mar; 79(3):621-3. PubMed ID: 12620451
[TBL] [Abstract][Full Text] [Related]
20. Comfort, ease of use and practicality of the pen injector for follitropin α for assisted reproduction: an observational post-marketing study in Egypt.
Yehia M; El-Khayat W; Kortam A; Mowafy AH; Aziz Khalifa AA; Awad A; Khattab S
Curr Med Res Opin; 2013 Nov; 29(11):1429-34. PubMed ID: 23899053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]